Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lapaquistat acetate is a squalene synthase inhibitor. It also blocks the conversion of farnesyl diphosphate (FPP) to squalene. Lapaquistat acetate is used to Mevalonate Kinase Deficiency (MKD), it is effective at lowering low-density lipoprotein cholesterol, but it might cause liver damage.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 977.00 | |
50 mg | 10-14 weeks | $ 1,270.00 | |
100 mg | 10-14 weeks | $ 1,930.00 |
Description | Lapaquistat acetate is a squalene synthase inhibitor. It also blocks the conversion of farnesyl diphosphate (FPP) to squalene. Lapaquistat acetate is used to Mevalonate Kinase Deficiency (MKD), it is effective at lowering low-density lipoprotein cholesterol, but it might cause liver damage. |
Synonyms | TAK-475 |
Molecular Weight | 645.14 |
Formula | C33H41ClN2O9 |
CAS No. | 189060-13-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 46 mg/mL (71.30 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lapaquistat acetate 189060-13-7 Others TAK 475 TAK475 Lapaquistat Acetate TAK-475 inhibitor inhibit